QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Expanding Focus Beyond HIV through Planned Acquisition
CytoDyn (OTCQB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, is now gearing…